• Thumbnail for Bavarian Nordic
    Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company...
    18 KB (1,166 words) - 08:15, 23 August 2024
  • Thumbnail for Smallpox vaccine
    Into the Strategic" (Press release). Retrieved 4 July 2022. Bavarian Nordic. "Bavarian Nordic Announces U.S. FDA Approval of Jynneos (Smallpox and Monkeypox...
    112 KB (12,177 words) - 20:51, 15 August 2024
  • Thumbnail for 2023–2024 mpox epidemic
    authorities in the DRC had approved the vaccines Jynneos, manufactured by Bavarian Nordic, and LC16, manufactured by KM Biologics, for emergency use. Jynneos...
    87 KB (6,708 words) - 00:52, 2 September 2024
  • Thumbnail for Timeline of the 2023–2024 mpox epidemic
    countries affected by the outbreak. The Danish pharmaceutical company Bavarian Nordic announced the submission of clinical data to the European Medicines...
    30 KB (2,757 words) - 18:19, 1 September 2024
  • Thumbnail for Monkeypox virus
    MVA-BN (marketed as Jynneos, Imvamune or Imvanex) manufactured by Bavarian Nordic. Licensed for use against mpox in Europe, United States and Canada...
    32 KB (4,433 words) - 05:21, 1 September 2024
  • Thumbnail for 2022–2023 mpox outbreak
    attenuated, non-replicating orthopoxvirus, Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN). The UKHSA has begun using Imvanex as post-exposure prophylaxis...
    181 KB (19,682 words) - 15:53, 30 August 2024
  • Thumbnail for 2022–2023 mpox outbreak in the United States
    "Bavarian Nordic to Manufacture First Freeze-Dried Doses of Smallpox Vaccine Upon Exercise of Contract Option by the U.S. Government". News. Bavarian Nordic...
    84 KB (5,239 words) - 12:48, 31 August 2024
  • Thumbnail for Mpox
    MVA-BN (marketed as Jynneos, Imvamune or Imvanex) manufactured by Bavarian Nordic. Licensed for use against mpox in Europe, United States and Canada...
    79 KB (7,035 words) - 21:23, 1 September 2024
  • Thumbnail for Ebola vaccine
    August 2020. Retrieved 16 July 2020 – via Reuters. Bavarian Nordic (15 July 2015). "Bavarian Nordic announces that the Oxford Vaccines Group has initiated...
    68 KB (6,256 words) - 15:34, 22 August 2024
  • Thumbnail for ABNCoV2
    developed by Expres2ion Biotechnologies and Adaptvac, outlicensed to Bavarian Nordic. On 9 August 2021, it was announced that the first round of trials...
    3 KB (170 words) - 14:16, 24 August 2023